Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining more than one drug may kill more tumor cells.
PURPOSE: This randomized phase II trial is studying two different regimens of combination
chemotherapy and comparing them to see how well they work in treating patients with high-risk
primary stage II or stage III breast cancer.